222 related articles for article (PubMed ID: 24574515)
1. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
Xu H; Zhang Y; Altomare D; Peña MM; Wan F; Pirisi L; Creek KE
Carcinogenesis; 2014 Jun; 35(6):1379-88. PubMed ID: 24574515
[TBL] [Abstract][Full Text] [Related]
2. Six1 overexpression at early stages of HPV16-mediated transformation of human keratinocytes promotes differentiation resistance and EMT.
Xu H; Pirisi L; Creek KE
Virology; 2015 Jan; 474():144-53. PubMed ID: 25463612
[TBL] [Abstract][Full Text] [Related]
3. HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression.
Hosseinipour M; Wan F; Altomare D; Creek KE; Pirisi L
Virology; 2019 Nov; 537():20-30. PubMed ID: 31425971
[TBL] [Abstract][Full Text] [Related]
4. TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes.
Kowli S; Velidandla R; Creek KE; Pirisi L
Virology; 2013 Dec; 447(1-2):63-73. PubMed ID: 24210100
[TBL] [Abstract][Full Text] [Related]
5. Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes.
Altomare D; Velidandla R; Pirisi L; Creek KE
BMC Cancer; 2013 Sep; 13():424. PubMed ID: 24047375
[TBL] [Abstract][Full Text] [Related]
6. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
7. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE
Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000
[TBL] [Abstract][Full Text] [Related]
8. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes.
Creek KE; Geslani G; Batova A; Pirisi L
Adv Exp Med Biol; 1995; 375():117-35. PubMed ID: 7645423
[TBL] [Abstract][Full Text] [Related]
9. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
[TBL] [Abstract][Full Text] [Related]
11. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
Hypes MK; Pirisi L; Creek KE
Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
[TBL] [Abstract][Full Text] [Related]
13. Six1 Promotes Epithelial-Mesenchymal Transition in Bronchial Epithelial Cells via the TGFβ1/Smad Signalling Pathway.
Wang W; Yang Z; Li M; Wang Z; Shan Y; Qu Z
Int Arch Allergy Immunol; 2021; 182(6):479-488. PubMed ID: 33631753
[TBL] [Abstract][Full Text] [Related]
14. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
15. SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancer.
Nishimura T; Tamaoki M; Komatsuzaki R; Oue N; Taniguchi H; Komatsu M; Aoyagi K; Minashi K; Chiwaki F; Shinohara H; Tachimori Y; Yasui W; Muto M; Yoshida T; Sakai Y; Sasaki H
Cancer Sci; 2017 Feb; 108(2):216-225. PubMed ID: 27987372
[TBL] [Abstract][Full Text] [Related]
16. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
Min WP; Wei XF
Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
[TBL] [Abstract][Full Text] [Related]
17. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
[TBL] [Abstract][Full Text] [Related]
18. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
[TBL] [Abstract][Full Text] [Related]
19. Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer.
Chen Y; Pirisi L; Creek KE
Virology; 2013 Sep; 444(1-2):100-8. PubMed ID: 23809940
[TBL] [Abstract][Full Text] [Related]
20. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer.
Wan F; Miao X; Quraishi I; Kennedy V; Creek KE; Pirisi L
Int J Cancer; 2008 Jul; 123(1):32-40. PubMed ID: 18398830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
